Interleukin-2--where are we going?
We have seen many advances in treatment modalities for patients infected with HIV. Trying to improve the immune system of our patients is one of them. An interesting treatment being investigated for this purpose is the use of interleukin-2. Interleukin-2 has been used in many clinical trials and is being used in ongoing trials. The successes/limitations of these trials have given us much information. Is immune reconstitution aided by the use of interleukin-2?
Conrad
Ann
A
AIDS Clinical Trials Unit, Department of Medicine-Infectious Diseases, MetroHealth Medical Center, Cleveland, Ohio, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology* / Q000821:virology; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D013601:T-Lymphocytes; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
D000276:Adjuvants, Immunologic; D007376:Interleukin-2